Ha-Neui Kim
Concepts (313)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Osteoclasts | 23 | 2021 | 425 | 3.690 |
Why?
| Bone Resorption | 12 | 2020 | 304 | 2.370 |
Why?
| Aging | 6 | 2021 | 687 | 2.110 |
Why?
| Osteogenesis | 7 | 2020 | 352 | 2.030 |
Why?
| RANK Ligand | 13 | 2020 | 179 | 1.550 |
Why?
| Osteoporosis | 3 | 2021 | 146 | 1.370 |
Why?
| Bone and Bones | 9 | 2020 | 469 | 1.270 |
Why?
| Mitochondria | 3 | 2021 | 402 | 1.270 |
Why?
| Histone Deacetylase Inhibitors | 3 | 2012 | 53 | 1.120 |
Why?
| Osteoblasts | 10 | 2021 | 450 | 1.100 |
Why?
| Estrogens | 4 | 2021 | 227 | 0.990 |
Why?
| Proto-Oncogene Proteins c-fos | 7 | 2013 | 61 | 0.980 |
Why?
| Mice | 28 | 2021 | 5739 | 0.860 |
Why?
| Forkhead Transcription Factors | 4 | 2017 | 112 | 0.860 |
Why?
| Carcinoma, Hepatocellular | 6 | 2010 | 191 | 0.810 |
Why?
| Cell Differentiation | 13 | 2020 | 651 | 0.800 |
Why?
| Benzamides | 2 | 2012 | 51 | 0.800 |
Why?
| Hepatitis B virus | 4 | 2009 | 27 | 0.800 |
Why?
| Adenosine Triphosphate | 2 | 2020 | 233 | 0.780 |
Why?
| Sirtuin 3 | 1 | 2021 | 19 | 0.770 |
Why?
| Hepatitis B, Chronic | 3 | 2010 | 16 | 0.760 |
Why?
| Pyridines | 2 | 2012 | 130 | 0.740 |
Why?
| Bone Density | 3 | 2020 | 379 | 0.740 |
Why?
| Monocyte-Macrophage Precursor Cells | 1 | 2020 | 7 | 0.730 |
Why?
| Stem Cells | 3 | 2019 | 171 | 0.730 |
Why?
| Oxidative Phosphorylation | 1 | 2020 | 39 | 0.720 |
Why?
| Animals | 31 | 2021 | 13187 | 0.700 |
Why?
| Sirtuin 1 | 2 | 2015 | 28 | 0.640 |
Why?
| Osteocytes | 1 | 2020 | 207 | 0.600 |
Why?
| Liver Abscess, Pyogenic | 1 | 2016 | 1 | 0.540 |
Why?
| Cecal Diseases | 1 | 2016 | 7 | 0.540 |
Why?
| Ulcer | 1 | 2016 | 22 | 0.530 |
Why?
| Signal Transduction | 9 | 2020 | 1618 | 0.520 |
Why?
| Liver Cirrhosis | 4 | 2011 | 218 | 0.500 |
Why?
| Mice, Knockout | 4 | 2021 | 841 | 0.500 |
Why?
| Liver Neoplasms | 5 | 2010 | 326 | 0.470 |
Why?
| Transcription, Genetic | 2 | 2015 | 369 | 0.470 |
Why?
| Hepatitis B e Antigens | 2 | 2010 | 4 | 0.450 |
Why?
| Bone Marrow Cells | 10 | 2015 | 191 | 0.440 |
Why?
| Mice, Inbred C57BL | 8 | 2020 | 1816 | 0.430 |
Why?
| Down-Regulation | 3 | 2012 | 348 | 0.410 |
Why?
| Trans-Activators | 2 | 2010 | 134 | 0.400 |
Why?
| NFATC Transcription Factors | 5 | 2013 | 23 | 0.400 |
Why?
| Antiviral Agents | 2 | 2010 | 173 | 0.390 |
Why?
| DEAD-box RNA Helicases | 1 | 2011 | 34 | 0.390 |
Why?
| Alkaline Phosphatase | 1 | 2011 | 94 | 0.380 |
Why?
| Female | 23 | 2021 | 26472 | 0.380 |
Why?
| Arabinofuranosyluracil | 1 | 2010 | 1 | 0.360 |
Why?
| Lamivudine | 1 | 2010 | 4 | 0.360 |
Why?
| Male | 29 | 2021 | 25241 | 0.360 |
Why?
| Ribavirin | 1 | 2010 | 15 | 0.350 |
Why?
| Interferon-alpha | 1 | 2010 | 47 | 0.350 |
Why?
| Hydroxamic Acids | 1 | 2009 | 38 | 0.340 |
Why?
| Gene Expression Regulation | 6 | 2020 | 976 | 0.340 |
Why?
| Polyethylene Glycols | 1 | 2010 | 93 | 0.340 |
Why?
| Mutation, Missense | 1 | 2009 | 105 | 0.330 |
Why?
| Hepatitis C, Chronic | 1 | 2010 | 83 | 0.320 |
Why?
| NF-kappa B | 3 | 2017 | 314 | 0.320 |
Why?
| Cells, Cultured | 9 | 2020 | 1573 | 0.320 |
Why?
| Hematopoietic Stem Cell Transplantation | 3 | 2017 | 565 | 0.300 |
Why?
| Graft vs Host Disease | 2 | 2017 | 75 | 0.280 |
Why?
| Mice, Inbred ICR | 6 | 2013 | 22 | 0.280 |
Why?
| Mice, Transgenic | 2 | 2019 | 555 | 0.270 |
Why?
| Coculture Techniques | 6 | 2013 | 146 | 0.270 |
Why?
| Estrogen Receptor alpha | 3 | 2016 | 89 | 0.260 |
Why?
| Skin Neoplasms | 2 | 2007 | 488 | 0.250 |
Why?
| Bone Neoplasms | 3 | 2012 | 179 | 0.240 |
Why?
| Interleukin-1 | 4 | 2013 | 104 | 0.230 |
Why?
| Neoplasm Recurrence, Local | 1 | 2007 | 614 | 0.220 |
Why?
| Cell Count | 2 | 2020 | 147 | 0.210 |
Why?
| Chemokine CXCL12 | 2 | 2020 | 32 | 0.210 |
Why?
| Humans | 25 | 2017 | 49974 | 0.200 |
Why?
| Bone Remodeling | 3 | 2020 | 150 | 0.200 |
Why?
| Middle Aged | 11 | 2017 | 12069 | 0.200 |
Why?
| Cell Lineage | 3 | 2016 | 83 | 0.190 |
Why?
| Porosity | 2 | 2017 | 30 | 0.190 |
Why?
| Osteolysis | 2 | 2012 | 75 | 0.190 |
Why?
| Sequence Analysis, DNA | 3 | 2012 | 237 | 0.180 |
Why?
| Tomography, X-Ray Computed | 5 | 2016 | 1159 | 0.180 |
Why?
| Chemokine CXCL10 | 2 | 2012 | 19 | 0.180 |
Why?
| Adipogenesis | 1 | 2020 | 51 | 0.180 |
Why?
| Phospholipids | 1 | 2020 | 57 | 0.180 |
Why?
| T-Lymphocytes, Regulatory | 2 | 2016 | 86 | 0.170 |
Why?
| Dinoprostone | 3 | 2009 | 53 | 0.170 |
Why?
| Mutation | 2 | 2017 | 1294 | 0.160 |
Why?
| Osteoprotegerin | 4 | 2013 | 52 | 0.160 |
Why?
| Antilymphocyte Serum | 1 | 2017 | 5 | 0.150 |
Why?
| Phenanthrenes | 2 | 2008 | 12 | 0.150 |
Why?
| Sulfonamides | 2 | 2017 | 129 | 0.150 |
Why?
| GATA4 Transcription Factor | 1 | 2017 | 11 | 0.150 |
Why?
| Hydrogen Peroxide | 2 | 2016 | 115 | 0.150 |
Why?
| G1 Phase Cell Cycle Checkpoints | 1 | 2017 | 17 | 0.150 |
Why?
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2017 | 67 | 0.140 |
Why?
| Panniculitis | 1 | 2017 | 7 | 0.140 |
Why?
| Myelodysplastic Syndromes | 1 | 2017 | 81 | 0.140 |
Why?
| Primary Cell Culture | 1 | 2017 | 61 | 0.140 |
Why?
| Genes, Reporter | 1 | 2017 | 89 | 0.140 |
Why?
| Luminescent Proteins | 1 | 2017 | 53 | 0.140 |
Why?
| Adult | 12 | 2017 | 13236 | 0.140 |
Why?
| Enzyme Activation | 2 | 2015 | 276 | 0.140 |
Why?
| Pancreatitis, Chronic | 1 | 2017 | 10 | 0.140 |
Why?
| Aniline Compounds | 1 | 2017 | 43 | 0.140 |
Why?
| Base Sequence | 3 | 2014 | 643 | 0.140 |
Why?
| Interleukin-2 | 1 | 2016 | 72 | 0.140 |
Why?
| DNA, Viral | 2 | 2009 | 133 | 0.140 |
Why?
| Gonadal Steroid Hormones | 1 | 2016 | 42 | 0.140 |
Why?
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2017 | 92 | 0.140 |
Why?
| Aged | 9 | 2017 | 9310 | 0.140 |
Why?
| Apoptosis | 2 | 2020 | 1101 | 0.140 |
Why?
| Killer Cells, Natural | 1 | 2016 | 95 | 0.130 |
Why?
| Leukemia, Myeloid, Acute | 1 | 2017 | 185 | 0.130 |
Why?
| Heme Oxygenase-1 | 1 | 2015 | 19 | 0.130 |
Why?
| Tumor Suppressor Protein p53 | 1 | 2017 | 202 | 0.130 |
Why?
| Antioxidants | 2 | 2009 | 249 | 0.130 |
Why?
| Colonoscopy | 1 | 2016 | 93 | 0.130 |
Why?
| Acetylation | 1 | 2015 | 97 | 0.130 |
Why?
| Liver | 2 | 2016 | 1115 | 0.130 |
Why?
| Receptors, Androgen | 1 | 2015 | 46 | 0.130 |
Why?
| DNA Damage | 1 | 2017 | 301 | 0.130 |
Why?
| Androgens | 1 | 2015 | 69 | 0.130 |
Why?
| Mitogen-Activated Protein Kinases | 1 | 2015 | 155 | 0.120 |
Why?
| Histones | 1 | 2017 | 312 | 0.120 |
Why?
| Hematologic Neoplasms | 1 | 2016 | 99 | 0.120 |
Why?
| Catalase | 1 | 2014 | 67 | 0.120 |
Why?
| Bone Development | 1 | 2014 | 65 | 0.120 |
Why?
| Laparoscopy | 1 | 2016 | 170 | 0.110 |
Why?
| Trapidil | 1 | 2013 | 1 | 0.110 |
Why?
| beta Catenin | 1 | 2014 | 102 | 0.110 |
Why?
| Molecular Sequence Data | 2 | 2012 | 792 | 0.110 |
Why?
| Viral Regulatory and Accessory Proteins | 2 | 2010 | 6 | 0.110 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2014 | 181 | 0.110 |
Why?
| Bone Density Conservation Agents | 1 | 2013 | 77 | 0.110 |
Why?
| Membrane Proteins | 2 | 2012 | 341 | 0.110 |
Why?
| Ovariectomy | 3 | 2020 | 119 | 0.100 |
Why?
| Antibodies, Monoclonal | 1 | 2016 | 459 | 0.100 |
Why?
| Osteogenesis Imperfecta | 1 | 2012 | 38 | 0.100 |
Why?
| Cell Nucleus | 1 | 2013 | 183 | 0.100 |
Why?
| Models, Biological | 1 | 2015 | 727 | 0.100 |
Why?
| Reactive Oxygen Species | 1 | 2014 | 408 | 0.100 |
Why?
| Cell Line | 2 | 2012 | 1000 | 0.100 |
Why?
| Janus Kinase 2 | 2 | 2008 | 26 | 0.100 |
Why?
| Viral Load | 2 | 2010 | 76 | 0.100 |
Why?
| Korea | 2 | 2009 | 7 | 0.100 |
Why?
| Platelet Aggregation Inhibitors | 1 | 2013 | 172 | 0.100 |
Why?
| Response Elements | 1 | 2011 | 29 | 0.100 |
Why?
| Gene Deletion | 3 | 2020 | 266 | 0.100 |
Why?
| Gene Knockdown Techniques | 1 | 2011 | 106 | 0.100 |
Why?
| Metronidazole | 1 | 2011 | 29 | 0.100 |
Why?
| Hepatic Encephalopathy | 1 | 2011 | 26 | 0.100 |
Why?
| Genotype | 2 | 2010 | 537 | 0.100 |
Why?
| Lipopolysaccharides | 2 | 2009 | 192 | 0.100 |
Why?
| Bone Regeneration | 1 | 2011 | 68 | 0.090 |
Why?
| Isoenzymes | 1 | 2011 | 168 | 0.090 |
Why?
| Histone Deacetylases | 1 | 2011 | 50 | 0.090 |
Why?
| Neoplasm Invasiveness | 2 | 2009 | 267 | 0.090 |
Why?
| Brain Diseases | 1 | 2011 | 82 | 0.090 |
Why?
| Drug Resistance, Viral | 1 | 2010 | 8 | 0.090 |
Why?
| Cyclic AMP Response Element-Binding Protein | 1 | 2010 | 34 | 0.090 |
Why?
| Anti-Infective Agents | 1 | 2011 | 95 | 0.090 |
Why?
| Vitamin E | 1 | 2011 | 81 | 0.090 |
Why?
| Enhancer Elements, Genetic | 1 | 2010 | 61 | 0.090 |
Why?
| Liver Function Tests | 1 | 2010 | 47 | 0.090 |
Why?
| Osteitis | 1 | 2009 | 1 | 0.090 |
Why?
| Catechin | 1 | 2009 | 28 | 0.090 |
Why?
| Protein Binding | 1 | 2011 | 660 | 0.090 |
Why?
| Hepatitis B Surface Antigens | 1 | 2009 | 9 | 0.080 |
Why?
| Protein Precursors | 1 | 2009 | 43 | 0.080 |
Why?
| Treatment Outcome | 2 | 2010 | 5141 | 0.080 |
Why?
| Skull | 1 | 2009 | 75 | 0.080 |
Why?
| Viral Envelope Proteins | 1 | 2009 | 30 | 0.080 |
Why?
| Gallbladder Neoplasms | 1 | 2009 | 5 | 0.080 |
Why?
| Macrophages | 2 | 2009 | 363 | 0.080 |
Why?
| RNA, Viral | 1 | 2010 | 125 | 0.080 |
Why?
| Tyrphostins | 1 | 2008 | 9 | 0.080 |
Why?
| Chromans | 1 | 2009 | 37 | 0.080 |
Why?
| Iodized Oil | 1 | 2008 | 1 | 0.080 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2014 | 595 | 0.080 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 83 | 0.080 |
Why?
| Chemoembolization, Therapeutic | 1 | 2008 | 12 | 0.080 |
Why?
| Intracranial Embolism | 1 | 2008 | 27 | 0.080 |
Why?
| Phylogeny | 1 | 2009 | 235 | 0.080 |
Why?
| Esophagoscopy | 1 | 2008 | 27 | 0.080 |
Why?
| Recombinant Proteins | 1 | 2010 | 486 | 0.080 |
Why?
| Toll-Like Receptor 5 | 1 | 2008 | 3 | 0.080 |
Why?
| MAP Kinase Signaling System | 1 | 2008 | 119 | 0.080 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2008 | 157 | 0.080 |
Why?
| STAT1 Transcription Factor | 1 | 2008 | 26 | 0.080 |
Why?
| Interferon-beta | 1 | 2008 | 29 | 0.080 |
Why?
| Promoter Regions, Genetic | 1 | 2010 | 475 | 0.080 |
Why?
| Rats, Sprague-Dawley | 1 | 2011 | 1597 | 0.070 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2008 | 121 | 0.070 |
Why?
| Arthritis, Rheumatoid | 1 | 2008 | 105 | 0.070 |
Why?
| Pulmonary Embolism | 1 | 2008 | 97 | 0.070 |
Why?
| Common Bile Duct Neoplasms | 1 | 2007 | 11 | 0.070 |
Why?
| Contrast Media | 1 | 2008 | 184 | 0.070 |
Why?
| Ampulla of Vater | 1 | 2007 | 17 | 0.070 |
Why?
| Esophageal Neoplasms | 1 | 2008 | 98 | 0.070 |
Why?
| Thioctic Acid | 1 | 2006 | 3 | 0.070 |
Why?
| Cholangitis | 1 | 2005 | 12 | 0.060 |
Why?
| Rats | 1 | 2011 | 3305 | 0.060 |
Why?
| X-Ray Microtomography | 2 | 2015 | 77 | 0.060 |
Why?
| Hepatitis B Core Antigens | 1 | 2004 | 7 | 0.060 |
Why?
| DNA Primers | 2 | 2014 | 207 | 0.060 |
Why?
| Organ Size | 2 | 2015 | 226 | 0.060 |
Why?
| Femur | 2 | 2015 | 133 | 0.060 |
Why?
| Adenocarcinoma | 1 | 2007 | 396 | 0.050 |
Why?
| Real-Time Polymerase Chain Reaction | 2 | 2014 | 181 | 0.050 |
Why?
| Breast Neoplasms | 1 | 2010 | 1174 | 0.050 |
Why?
| Antibodies, Neutralizing | 1 | 2020 | 64 | 0.050 |
Why?
| Homeodomain Proteins | 1 | 2020 | 80 | 0.040 |
Why?
| Oxidation-Reduction | 1 | 2020 | 322 | 0.040 |
Why?
| Adolescent | 4 | 2017 | 6356 | 0.040 |
Why?
| Blotting, Western | 2 | 2014 | 601 | 0.040 |
Why?
| Cell Survival | 2 | 2011 | 600 | 0.040 |
Why?
| HLA Antigens | 1 | 2017 | 52 | 0.040 |
Why?
| Cyclooxygenase 2 | 2 | 2008 | 45 | 0.040 |
Why?
| Amylases | 1 | 2017 | 5 | 0.040 |
Why?
| Liver Cirrhosis, Alcoholic | 1 | 2017 | 6 | 0.040 |
Why?
| Age Factors | 1 | 2020 | 1087 | 0.040 |
Why?
| Methotrexate | 1 | 2017 | 69 | 0.040 |
Why?
| Lipase | 1 | 2017 | 13 | 0.040 |
Why?
| Tacrolimus | 1 | 2017 | 52 | 0.040 |
Why?
| Fatal Outcome | 2 | 2008 | 195 | 0.040 |
Why?
| Laboratories | 1 | 2017 | 21 | 0.040 |
Why?
| Cell Line, Tumor | 2 | 2012 | 1403 | 0.040 |
Why?
| STAT5 Transcription Factor | 1 | 2016 | 10 | 0.040 |
Why?
| Mice, Inbred BALB C | 1 | 2017 | 304 | 0.040 |
Why?
| Erythema | 1 | 2017 | 38 | 0.040 |
Why?
| Myeloid Cells | 1 | 2016 | 38 | 0.040 |
Why?
| Models, Animal | 1 | 2017 | 233 | 0.040 |
Why?
| Transplantation Immunology | 1 | 2016 | 6 | 0.030 |
Why?
| CD4 Lymphocyte Count | 1 | 2016 | 32 | 0.030 |
Why?
| Calcification, Physiologic | 1 | 2016 | 41 | 0.030 |
Why?
| Receptor Activator of Nuclear Factor-kappa B | 2 | 2006 | 30 | 0.030 |
Why?
| Induction Chemotherapy | 1 | 2016 | 60 | 0.030 |
Why?
| Myeloproliferative Disorders | 1 | 2016 | 27 | 0.030 |
Why?
| Transplantation, Homologous | 1 | 2016 | 139 | 0.030 |
Why?
| Immunosuppressive Agents | 1 | 2017 | 221 | 0.030 |
Why?
| Leukemia | 1 | 2016 | 65 | 0.030 |
Why?
| Double-Blind Method | 1 | 2017 | 681 | 0.030 |
Why?
| Lymphoma | 1 | 2016 | 66 | 0.030 |
Why?
| Orchiectomy | 1 | 2015 | 41 | 0.030 |
Why?
| Integrases | 1 | 2015 | 43 | 0.030 |
Why?
| Membrane Glycoproteins | 2 | 2006 | 240 | 0.030 |
Why?
| Gene Expression | 2 | 2008 | 609 | 0.030 |
Why?
| Recurrence | 1 | 2016 | 652 | 0.030 |
Why?
| Carrier Proteins | 2 | 2006 | 304 | 0.030 |
Why?
| Wnt Proteins | 1 | 2014 | 100 | 0.030 |
Why?
| Proto-Oncogene Proteins c-pim-1 | 1 | 2013 | 1 | 0.030 |
Why?
| Skin | 1 | 2017 | 409 | 0.030 |
Why?
| Atrophy | 1 | 2013 | 38 | 0.030 |
Why?
| Inflammation | 2 | 2008 | 604 | 0.030 |
Why?
| Analysis of Variance | 1 | 2014 | 562 | 0.030 |
Why?
| Genetic Linkage | 1 | 2012 | 26 | 0.030 |
Why?
| 5' Untranslated Regions | 1 | 2012 | 31 | 0.030 |
Why?
| Exome | 1 | 2012 | 46 | 0.030 |
Why?
| Uterus | 1 | 2013 | 94 | 0.030 |
Why?
| Point Mutation | 1 | 2012 | 65 | 0.030 |
Why?
| Phenotype | 1 | 2015 | 729 | 0.030 |
Why?
| Spine | 1 | 2013 | 94 | 0.030 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 244 | 0.020 |
Why?
| Estradiol | 1 | 2013 | 225 | 0.020 |
Why?
| Prospective Studies | 1 | 2017 | 2364 | 0.020 |
Why?
| Calcium | 1 | 2013 | 396 | 0.020 |
Why?
| Radiography | 1 | 2012 | 489 | 0.020 |
Why?
| Amino Acid Sequence | 1 | 2012 | 585 | 0.020 |
Why?
| Tocotrienols | 1 | 2011 | 37 | 0.020 |
Why?
| Tumor Microenvironment | 1 | 2012 | 212 | 0.020 |
Why?
| Matrix Metalloproteinases | 1 | 2010 | 48 | 0.020 |
Why?
| Parathyroid Hormone-Related Protein | 1 | 2010 | 23 | 0.020 |
Why?
| Interleukin-17 | 1 | 2010 | 36 | 0.020 |
Why?
| Cell Proliferation | 1 | 2014 | 1007 | 0.020 |
Why?
| Mice, Nude | 1 | 2010 | 252 | 0.020 |
Why?
| Xenograft Model Antitumor Assays | 1 | 2010 | 211 | 0.020 |
Why?
| Insulin-Like Growth Factor I | 1 | 2010 | 137 | 0.020 |
Why?
| Neoplasm Metastasis | 1 | 2010 | 231 | 0.020 |
Why?
| Transforming Growth Factor beta | 1 | 2010 | 144 | 0.020 |
Why?
| bcl-Associated Death Protein | 1 | 2008 | 9 | 0.020 |
Why?
| Drugs, Chinese Herbal | 1 | 2008 | 5 | 0.020 |
Why?
| Cytochromes c | 1 | 2008 | 29 | 0.020 |
Why?
| Apoptosis Regulatory Proteins | 1 | 2008 | 86 | 0.020 |
Why?
| Mucous Membrane | 1 | 2008 | 28 | 0.020 |
Why?
| Oxidative Stress | 1 | 2013 | 770 | 0.020 |
Why?
| Caspases | 1 | 2008 | 104 | 0.020 |
Why?
| Mice, Inbred DBA | 1 | 2008 | 45 | 0.020 |
Why?
| Flagellin | 1 | 2008 | 4 | 0.020 |
Why?
| Polyps | 1 | 2008 | 21 | 0.020 |
Why?
| Proto-Oncogene Proteins | 1 | 2008 | 149 | 0.020 |
Why?
| Mice, Mutant Strains | 1 | 2008 | 71 | 0.020 |
Why?
| Young Adult | 1 | 2017 | 3958 | 0.020 |
Why?
| Endosonography | 1 | 2008 | 92 | 0.020 |
Why?
| Diffusion Magnetic Resonance Imaging | 1 | 2008 | 123 | 0.020 |
Why?
| Biopsy, Needle | 1 | 2008 | 183 | 0.020 |
Why?
| Adaptor Proteins, Vesicular Transport | 1 | 2008 | 43 | 0.020 |
Why?
| Bone Diseases | 1 | 2008 | 99 | 0.020 |
Why?
| Ultrasonography | 1 | 2009 | 436 | 0.020 |
Why?
| Protein Biosynthesis | 1 | 2009 | 253 | 0.020 |
Why?
| Protein Kinase Inhibitors | 1 | 2008 | 204 | 0.020 |
Why?
| Macrophage Colony-Stimulating Factor | 1 | 2006 | 11 | 0.020 |
Why?
| Child | 2 | 2012 | 6847 | 0.020 |
Why?
| Immunoblotting | 1 | 2006 | 118 | 0.020 |
Why?
| Nitrobenzenes | 1 | 2006 | 2 | 0.020 |
Why?
| Palliative Care | 1 | 2008 | 187 | 0.020 |
Why?
| Gene Expression Regulation, Neoplastic | 1 | 2010 | 828 | 0.020 |
Why?
| Cyclooxygenase Inhibitors | 1 | 2006 | 39 | 0.020 |
Why?
| Neoplasm Staging | 1 | 2008 | 740 | 0.020 |
Why?
| Diagnosis, Differential | 1 | 2009 | 1037 | 0.020 |
Why?
| Immunohistochemistry | 1 | 2008 | 973 | 0.020 |
Why?
| Disease Progression | 1 | 2008 | 825 | 0.020 |
Why?
| Acute Disease | 1 | 2005 | 366 | 0.010 |
Why?
| Magnetic Resonance Imaging | 1 | 2011 | 1537 | 0.010 |
Why?
| Disease Models, Animal | 1 | 2008 | 1455 | 0.010 |
Why?
| Prognosis | 1 | 2007 | 1942 | 0.010 |
Why?
|
|
Kim's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|